FDA approved LyGenesis' phase 2a trials on liver failure patients
Longevity Technology - 30-Dec-2020Raised $11M funding which goes into trials and developing functional organs
Longevity Vision Fund
$100M life extension-focused investment fund
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of aging
Longevity Vision Fund provides Seed to Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation
Our investment activity focuses on the following sectors:
Preventive Medicine & Early Detection
Medical Technologies & Devices
Artificial Intelligence (AI) in Healthcare
Longevity Therapies & Regenerative Medicine
Healthcare Infrastructure
Visit website: https://lvf.vc/
Details last updated 30-Apr-2020
People at Longevity Vision Fund
Longevity Vision Fund News
Why 3D supplement printing holds a bright future for longevity
Forbes - 28-Apr-2020Vast potential when tapped for pharmaceutical medicine use as well
Longevity Vision Fund joins Series B funding for Sigilon Therapeutics
Longevity Vision Fund - 20-Apr-2020To support human clinical trial of novel encapsulated cell therapy for hemophilia A
